B-Cell	0	5	Cells	Cell	NNS	B-NP
O	6	17	transformed	transform	VBN	B-VP
O	18	20	by	by	IN	B-PP
O	21	25	Rous	Rous	NNP	B-NP
O	26	33	sarcoma	sarcoma	NN	I-NP
O	34	39	virus	virus	NN	I-NP
O	40	47	release	release	NN	I-NP
O	48	60	transforming	transform	VBG	B-VP
O	61	67	growth	growth	NN	B-NP
O	68	75	factors	factor	NNS	I-NP
O	75	76	.	.	.	O

O	78	85	Chicken	Chicken	NN	B-NP
B-Cell	86	92	embryo	embryo	NN	I-NP
I-Cell	93	104	fibroblasts	fibroblast	NNS	I-NP
O	105	108	and	and	CC	O
B-Cell	109	116	hamster	hamster	NN	B-NP
I-Cell	117	120	BHK	BHK	NN	I-NP
I-Cell	121	126	cells	cell	NNS	I-NP
O	127	138	transformed	transform	VBN	B-VP
O	139	141	by	by	IN	B-PP
O	142	146	Rous	Rous	NNP	B-NP
O	147	154	sarcoma	sarcoma	NN	I-NP
O	155	160	virus	virus	NN	I-NP
O	161	162	(	(	(	O
O	162	165	RSV	RSV	NN	B-NP
O	165	166	)	)	)	O
O	167	174	release	release	NN	B-NP
O	175	177	in	in	IN	B-PP
O	178	183	their	their	PRP$	B-NP
O	184	191	culture	culture	NN	I-NP
O	192	197	media	medium	NNS	I-NP
O	198	204	growth	growth	NN	I-NP
O	205	212	factors	factor	NNS	I-NP
O	213	218	which	which	WDT	B-NP
O	219	226	enhance	enhance	VBP	B-VP
O	227	235	markedly	markedly	RB	B-ADVP
O	236	245	anchorage	anchorage	NN	B-NP
O	245	246	-	-	HYPH	I-NP
O	246	257	independent	independent	JJ	I-NP
B-Cell	258	264	colony	colony	NN	I-NP
O	265	274	formation	formation	NN	I-NP
O	275	277	in	in	IN	B-PP
O	278	286	gelified	gelifie	VBN	B-NP
O	287	293	medium	medium	NN	I-NP
O	293	294	,	,	,	O
O	295	297	at	at	IN	B-PP
O	298	301	the	the	DT	B-NP
O	302	313	restrictive	restrictive	JJ	I-NP
O	314	325	temperature	temperature	NN	I-NP
O	326	327	(	(	(	O
O	327	329	41	41	CD	B-NP
O	330	337	degrees	degree	NNS	I-NP
O	338	339	5	5	CD	B-NP
O	340	341	C	C	NN	I-NP
O	341	342	)	)	)	O
O	342	343	,	,	,	O
O	344	346	of	of	IN	B-PP
O	347	354	chicken	chicken	NN	B-NP
B-Cell	355	361	embryo	embryo	NN	I-NP
I-Cell	362	373	fibroblasts	fibroblast	NNS	I-NP
O	374	375	(	(	(	O
B-Cell	375	378	CEF	CEF	NN	B-NP
O	378	379	)	)	)	O
O	380	388	infected	infect	VBN	B-VP
O	389	391	by	by	IN	B-PP
O	392	395	RSV	RSV	NN	B-NP
O	396	403	mutants	mutant	NNS	I-NP
O	404	408	with	with	IN	B-PP
O	409	410	a	a	DT	B-NP
O	411	413	ts	t	NNS	I-NP
O	414	422	mutation	mutation	NN	I-NP
O	423	425	of	of	IN	B-PP
O	426	429	the	the	DT	B-NP
O	430	433	src	src	NN	I-NP
O	434	438	gene	gene	NN	I-NP
O	438	439	.	.	.	O

O	440	444	This	This	DT	B-NP
O	445	451	action	action	NN	I-NP
O	452	454	is	be	VBZ	B-VP
O	455	458	not	not	RB	I-VP
O	459	467	observed	observe	VBN	I-VP
O	468	472	with	with	IN	B-PP
O	473	483	uninfected	uninfected	JJ	B-NP
B-Cell	484	487	CEF	CEF	NN	I-NP
O	487	488	,	,	,	O
O	489	492	and	and	CC	O
O	492	493	,	,	,	O
O	494	503	therefore	therefore	RB	B-ADVP
O	503	504	,	,	,	O
O	505	512	appears	appear	VBZ	B-VP
O	513	515	to	to	TO	I-VP
O	516	523	require	require	VB	I-VP
O	524	528	some	some	DT	B-NP
O	529	539	expression	expression	NN	I-NP
O	540	542	of	of	IN	B-PP
O	543	546	the	the	DT	B-NP
O	547	552	viral	viral	JJ	I-NP
O	553	556	src	src	NN	I-NP
O	557	561	gene	gene	NN	I-NP
O	562	564	in	in	IN	B-PP
O	565	568	the	the	DT	B-NP
O	569	575	target	target	NN	I-NP
B-Cell	576	581	cells	cell	NNS	I-NP
O	581	582	.	.	.	O

O	583	586	The	The	DT	B-NP
O	587	596	enhancing	enhance	VBG	I-NP
O	597	604	factors	factor	NNS	I-NP
O	605	608	are	be	VBP	B-VP
O	609	617	proteins	protein	NNS	B-NP
O	618	625	related	relate	VBN	B-VP
O	626	628	to	to	TO	B-PP
O	629	632	the	the	DT	B-NP
O	633	639	family	family	NN	I-NP
O	640	642	of	of	IN	B-PP
O	643	646	the	the	DT	B-NP
O	647	659	transforming	transform	VBG	I-NP
O	660	666	growth	growth	NN	I-NP
O	667	674	factors	factor	NNS	I-NP
O	675	676	(	(	(	O
O	676	680	TGFs	TGF	NNS	B-NP
O	680	681	)	)	)	O
O	682	684	by	by	IN	B-PP
O	685	690	their	their	PRP$	B-NP
O	691	700	molecular	molecular	JJ	I-NP
O	701	707	weight	weight	NN	I-NP
O	708	709	(	(	(	O
O	709	714	about	about	RB	B-NP
O	715	717	20	20	CD	I-NP
O	718	720	kd	kd	NN	I-NP
O	720	721	)	)	)	O
O	721	722	,	,	,	O
O	723	728	their	their	PRP$	B-NP
O	729	733	heat	heat	NN	I-NP
O	734	737	and	and	CC	I-NP
O	738	742	acid	acid	NN	I-NP
O	743	753	resistance	resistance	NN	I-NP
O	753	754	,	,	,	O
O	755	758	and	and	CC	O
O	759	764	their	their	PRP$	B-NP
O	765	776	sensitivity	sensitivity	NN	I-NP
O	777	779	to	to	TO	B-PP
O	780	794	dithiothreitol	dithiothreitol	NN	B-NP
O	794	795	.	.	.	O

O	796	800	They	They	PRP	B-NP
O	801	803	do	do	VBP	B-VP
O	804	807	not	not	RB	I-VP
O	808	815	compete	compete	VB	I-VP
O	816	820	with	with	IN	B-PP
O	821	825	125I	125I	NN	B-NP
O	826	829	EGF	EGF	NN	I-NP
O	830	833	for	for	IN	B-PP
O	834	841	binding	binding	NN	B-NP
O	842	844	on	on	IN	B-PP
O	845	848	the	the	DT	B-NP
O	849	852	EGF	EGF	NN	I-NP
O	853	862	receptors	receptor	NNS	I-NP
O	863	865	of	of	IN	B-PP
O	866	869	the	the	DT	B-NP
B-Cellular_component	870	878	membrane	membrane	NN	I-NP
O	879	881	of	of	IN	B-PP
B-Cell	882	886	A431	A431	NN	B-NP
I-Cell	887	892	cells	cell	NNS	I-NP
O	892	893	.	.	.	O

O	894	896	As	As	IN	B-SBAR
O	897	904	chicken	chicken	NN	B-NP
B-Cell	905	911	embryo	embryo	NN	I-NP
I-Cell	912	923	fibroblasts	fibroblast	NNS	I-NP
O	924	927	are	be	VBP	B-VP
O	928	934	devoid	devoid	JJ	B-ADJP
O	935	937	of	of	IN	B-PP
O	938	941	EGF	EGF	NN	B-NP
O	942	951	receptors	receptor	NNS	I-NP
O	951	952	,	,	,	O
O	953	958	their	their	PRP$	B-NP
O	959	967	activity	activity	NN	I-NP
O	968	970	is	be	VBZ	B-VP
O	971	974	not	not	RB	I-VP
O	975	986	potentiated	potentiate	VBN	I-VP
O	987	989	by	by	IN	B-PP
O	990	993	EGF	EGF	NN	B-NP
O	993	994	.	.	.	O

